In conclusion, our study confirmed that Sestrin2 alleviated inflammation and endoplasmic reticulum stress-dependent ferroptosis through the NRF2/ATF4 pathway to reduce PF at the cellular and animal levels, which may indicate new therapeutic targets and ideas for the clinical treatment of PF. This evidence concerns the gene ATF4 and pemphigus foliaceus.